1. All Products
  2. IMMUNOGL. SNAKE ANTIVENOM, Africa (EchiTab-ICP) pwd+dil vial
Public Pricelist

IMMUNOGL. SNAKE ANTIVENOM, Africa (EchiTab-ICP) pwd+dil vial

https://unicat.msf.org/cat/product/94825
NST DVACIMAS19V

Valid Article

The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
19.2 - Sera, immunoglobulins and monoclonal antibodies
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J06AA03
Anatomical Therapeutic Chemical Classification according to WHOCC
MF
The order of this product needs to be justified and is only acceptable under certain conditions.
CT30
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

IMMUNOGLOBULIN SNAKE ANTIVENOM, Africa (EchiTab-ICP)

This product is not always available at supply centres level. Contact your HQ advisor and check the specifications if an alternative is offered.

Full Name

EchiTab-ICP, lyophilized Polyspecific Snake Antivenom

Therapeutic Action

Neutralisation of snake venom

Equine serum globulins

Indications

Treatment of snakebite envenomations from 22 African species found in sub-Saharan Africa, including:

  • Puff adder (Bitis arietans)
  • West African carpet viper (Echis ocellatus)
  • Black-necked spitting cobra (Naja nigricollis)
  • Black Mamba (Dendroaspis polyepis)
Some restricted information has been hidden. Sign in to see this information

Instructions for use

Lyophilised vial with diluent.

Reconstitute the powder vial with the diluent supplied to obtain a reconstituted 10 ml solution.

Must be given as IM injection or IV infusion (after dilution in 0.9% NaCl).

The minimum dose in case of envenomation is 4 vials.

Read the manufacturer's instructions.

Precautions for Use

Appropriate medical treatment should always be readily available in case of anaphylactic reactions following the administration of the product.

Storage

  • Below 25ºC
  • After reconstitution, use the product immediately.